Similar articles for PMID: 36653115

Year	Number of Results
1994	2
2005	1
2006	1
2007	1
2009	1
2010	3
2011	6
2012	7
2013	5
2014	12
2015	13
2016	7
2017	13
2018	14
2019	18
2020	5
2021	6
2022	17
2023	35
2024	27
2025	1

1

Denosumab versus Bisphosphonates for Reducing Fractures in Postmenopausal Women with Osteoporosis: A Meta-Analysis.

Thal KA, Nudy M, Moser EM, Foy AJ. Thal KA, et al. J Am Board Fam Med. 2023 Feb 8;36(1):175-185. doi: 10.3122/jabfm.2022.220099R1. Epub 2023 Jan 18. J Am Board Fam Med. 2023. PMID: 36653115 Free article.

2

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.

Händel MN, Cardoso I, von Bülow C, Rohde JF, Ussing A, Nielsen SM, Christensen R, Body JJ, Brandi ML, Diez-Perez A, Hadji P, Javaid MK, Lems WF, Nogues X, Roux C, Minisola S, Kurth A, Thomas T, Prieto-Alhambra D, Ferrari SL, Langdahl B, Abrahamsen B. Händel MN, et al. BMJ. 2023 May 2;381:e068033. doi: 10.1136/bmj-2021-068033. BMJ. 2023. PMID: 37130601 Free PMC article.

3

The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis.

Moshi MR, Nicolopoulos K, Stringer D, Ma N, Jenal M, Vreugdenburg T. Moshi MR, et al. Calcif Tissue Int. 2023 Jun;112(6):631-646. doi: 10.1007/s00223-023-01078-z. Epub 2023 Apr 5. Calcif Tissue Int. 2023. PMID: 37016189

4

Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.

Li M, Ge Z, Zhang B, Sun L, Wang Z, Zou T, Chen Q. Li M, et al. Arch Osteoporos. 2024 Sep 23;19(1):89. doi: 10.1007/s11657-024-01447-7. Arch Osteoporos. 2024. PMID: 39312040 Free PMC article.

5

Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate.

Brown JP, Roux C, Ho PR, Bolognese MA, Hall J, Bone HG, Bonnick S, van den Bergh JP, Ferreira I, Dakin P, Wagman RB, Recknor C. Brown JP, et al. Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28. Osteoporos Int. 2014. PMID: 24676847

6

Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women.

Ellis AG, Reginster JY, Luo X, Bushmakin AG, Williams R, Sutradhar S, Mirkin S, Jansen JP. Ellis AG, et al. Curr Med Res Opin. 2014 Aug;30(8):1617-26. doi: 10.1185/03007995.2014.908279. Epub 2014 May 2. Curr Med Res Opin. 2014. PMID: 24773456 Review.

7

Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Viswanathan M, Reddy S, Berkman N, Cullen K, Middleton JC, Nicholson WK, Kahwati LC. Viswanathan M, et al. JAMA. 2018 Jun 26;319(24):2532-2551. doi: 10.1001/jama.2018.6537. JAMA. 2018. PMID: 29946734

8

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis.

Wu J, Zhang Q, Yan G, Jin X. Wu J, et al. J Orthop Surg Res. 2018 Aug 2;13(1):194. doi: 10.1186/s13018-018-0865-3. J Orthop Surg Res. 2018. PMID: 30071889 Free PMC article.

9

Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis.

Simpson EL, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P, Davis S. Simpson EL, et al. Bone. 2020 Jan;130:115081. doi: 10.1016/j.bone.2019.115081. Epub 2019 Oct 15. Bone. 2020. PMID: 31626995

10

An overview of the management of osteoporosis in the aging female population.

Amin U, McPartland A, O'Sullivan M, Silke C. Amin U, et al. Womens Health (Lond). 2023 Jan-Dec;19:17455057231176655. doi: 10.1177/17455057231176655. Womens Health (Lond). 2023. PMID: 37218715 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 36653115

170 results

Results by year